2020
Medical marijuana certification for patients with sickle cell disease: a report of a single center experience
Curtis SA, Lew D, Spodick J, Hendrickson JE, Minniti CP, Roberts JD. Medical marijuana certification for patients with sickle cell disease: a report of a single center experience. Blood Advances 2020, 4: 3814-3821. PMID: 32790846, PMCID: PMC7448584, DOI: 10.1182/bloodadvances.2020002325.Peer-Reviewed Original ResearchConceptsOpioid useMedical marijuanaSickle cell disease (SCD) reportBaseline opioid useSingle-center experienceHealth care utilizationSickle cell diseaseOpioid utilizationClinical characteristicsMost patientsCenter experienceCare utilizationSCD patientsInpatient hospitalizationRandom patientsAdmission ratesCell diseasePatientsRetrospective dataDisease reportsStudy periodHealth careCannabis productsCannabisEdible cannabis products
2007
Depression and Anxiety in Adults With Sickle Cell Disease: The PiSCES Project
Levenson JL, McClish DK, Dahman BA, Bovbjerg VE, de A. Citero V, Penberthy LT, Aisiku IP, Roberts JD, Roseff SD, Smith WR. Depression and Anxiety in Adults With Sickle Cell Disease: The PiSCES Project. Psychosomatic Medicine 2007, 70: 192-196. PMID: 18158366, DOI: 10.1097/psy.0b013e31815ff5c5.Peer-Reviewed Original ResearchConceptsSickle cell diseaseSCD adultsCell diseaseDepressed subjectsSickle Cell Epidemiology StudyHigher mean painProspective cohort studyHealth-related qualitySF-36 subscalesPrevalence of depressionSickle cell crisisDomains of qualityMean painPain daysPiSCES projectOpioid usageOpioid utilizationCohort studyDaily painPain intensityHealthcare utilizationMore painBaseline variablesCell crisisHemoglobin types